Wedbush assumed coverage on Imperva (NYSE: IMPV) with a Neutral rating and a modified price target of $31.00 (from $51.00).Analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE